Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Scientists have found that statins -- commonly used cholesterol-lowering drugs -- may block a pathway that leads to the development of cancer in the context of chronic inflammation. A new study led by ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Starton Holdings filed for an initial public offering, as it works to develop a treatment for blood cancers. The clinical-stage biotechnology company plans to offer about 6.7 million shares priced at ...